Skip to content

Impact of photobiomodulation in the salivary flow of patients treated with radiotherapy and chemotherapy for head and neck cancer: double blind and randomized pilot study.

Impact of photobiomodulation in the salivary flow of patients treated with radiotherapy and chemotherapy for head and neck cancer: double blind and randomized pilot study.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-5746z9
Enrollment
Unknown
Registered
2020-05-04
Start date
2019-02-23
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Xerostomia

Interventions

A randomized double-blind clinical trial was carried out to compare changes in the salivary flow of patients undergoing treatment for head and neck cancer with radiotherapy, submitted to two different
Procedure/surgery
E07.632.490
E02.594.540

Sponsors

Próprio pesquisador
Lead Sponsor
Universidade Federal de Pernambuco
Collaborator

Eligibility

Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: Patients with cancer of the head and neck (oral cavity, pharynx, larynx and occult primary) with indication of treatment with radiotherapy; Patients that the irradiation field must include all major salivary glands.

Exclusion criteria

Exclusion criteria: Patients younger than 18 years or incapacitated to answer questions; Initial tumors (T1 and T2) and limited to the larynx, other sites such as metastases and skin tumors; Indication of RT with palliative intent; Patients with Diabetes Melitus, autoimmune, infectious and collagen diseases. Patients who use drugs that may interfere with the salivary flow; Patients with trismus or limitation of mouth opening due to surgical sequelae.

Design outcomes

Primary

MeasureTime frame
Expected outcome 1 It was expected that at D3, one month after the end of radiotherapy, patients belonging to the intervention group would have maintained an unstimulated salivary flow greater than 0.2 ml / min (grade 1) and lower degrees of xerostomia when compared to the placebo group, measured through unstimulated sialometry and the application of the xerostomia inventory.;Outcome found 1 The patients in the intervention group maintained an unstimulated salivary flow greater than 0.2 ml / min after one month of radiotherapy. They also maintained lower xerostomy inventory values ??than the control group for one month after completion, indicating less severe xerostomy.

Secondary

MeasureTime frame
Expected outcome 2 It was expected that patients in the intervention group had a lower prevalence of oral complications associated with hyposalivation than patients in the control group.;Outcome found 2 A lower prevalence of oral complications associated with hyposalivation (mucositis, fungal infections, dysphagia, oral pain) was observed in the intervention group when compared to the control group, confirming the expected outcome 2.

Countries

Brazil

Contacts

Public ContactRaylane de Albuquerque

Universidade Federal de Pernambuco

nanealbuquerque_@hotmail.com+55 81 981515139

Outcome results

None listed

Source: REBEC (via WHO ICTRP)